Vitroscope, a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time, has raised $7 million, comprising a $5 million seed roun…
This is a summary
The full article is published by Tech.eu. We hold only a headline and a short summary here.
Read the full article